Providing reduced-risk alternatives to adult smokers who would otherwise continue smoking cigarettes is the basis of “tobacco harm reduction.” From snus, the popular smokeless tobacco product in Sweden, to electronic cigarettes and other innovative products, alternatives to combustible cigarettes are increasingly recognized as an important public health tool to complement policies focused on the prevention of smoking initiation and smoking cessation. Our objective with RRPs is to develop products that reduce or eliminate harmful and potentially harmful constituents, while delivering adult smoker satisfaction.
“To the extent that certain products are shown to be less harmful, they could help reduce the overall death and disease toll from tobacco use…This is a function of the existence of a continuum of nicotine-delivering products that pose differing levels of risk to the individual.”
- US Food and Drug AdministrationDeeming Tobacco Products To Be Subject to the Federal Food, Drug and Cosmetic Act. 21 CFR Parts 1100,1140 and 1143
"Emerging technologies such as the e-cigarette may have the potential to reduce the death and disease toll from overall tobacco product use depending on who uses the products and how they are used.....there is a potential for the net impact at the population level to be positive." - US Food and Drug AdministrationDeeming Tobacco Products To Be Subject to the Federal Food, Drug and Cosmetic Act. 21 CFR Parts 1100,1140 and 1143
We are currently working on four product platforms – two with tobacco and two without tobacco – that have the potential to reduce the risk of smoking-related diseases. These products are at various stages of development and assessment:
“[Legislation addressing risk reduction] may be valuable tools in the effort to promote public health by reducing the morbidity and mortality associated with tobacco use, particularly if companies take advantage of these provisions by making bold, innovative product changes…”
- US Food and Drug Administration
All newly developed RRP platforms have been developed to reduce risk while maintaining product acceptance and appeal and will undergo rigorous assessment.
Reduced-Risk Products (“RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce far lower quantities of harmful and potentially harmful compounds than found in cigarette smoke.